Mutational Screening of (CLN6), (CLN7) and (CLN14) Genes in Egyptian Patients with Neuronal Ceroid Lipofuscinosis. | ||||
Azhar International Journal of Pharmaceutical and Medical Sciences | ||||
Article 8, Volume 4, Issue 1, January 2024, Page 91-97 PDF (583.62 K) | ||||
Document Type: Original research articles | ||||
DOI: 10.21608/aijpms.2023.163148.1169 | ||||
View on SCiNiTO | ||||
Authors | ||||
Mona A Srour 1; Maha S Zaki2; Abeer I Abd El-Fattah1; Asmaa S Ali1; Mahmoud Y Isaa3; Miral Refeat3 | ||||
1Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt | ||||
2Department of Clinical Genetics, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt. | ||||
3Department of Medical Molecular Genetics, Human Genetics and Genome Research Institute, National Research Centre, Egypt | ||||
Abstract | ||||
Neuronal ceroid lipofuscinoses (NCL), the commonest autosomal recessive neurodegenerative disorder, is marked by an accumulation of auto-fluorescent storage material, primarily in neurons. NCL affects the neurons and causes damage due to accumulation of auto-fluorescent lysosomal storage material inside the neuronal cytoplasm. Although it is a rare fatal childhood disorder, childhood, patients born with it suffer life threatening complications and disabilities that deteriorates their quality of life. The current study aims to screen for mutations in CLN 6,7, and 14 genes in twenty Egyptian patients clinically diagnosed with seizures, Retinal degeneration, progressive mental deterioration and ataxia, using direct Sanger sequencing. Two reported mutations have been detected in CLN6 gene, homozygous missense (c.299T>G) and 3-bp deletion (c.711_713delCTT) in two different cases who are not siblings, and the other eighteen patients had no genetic defects in the enrolled genes. Further studies on larger number of participants are required in order to further clarify the causative CLN genes, particularlyCLN6, CLN7 and CLN14 among Egyptian patients. | ||||
Keywords | ||||
Mutation; Neuronal ceroid lipofuscinoses (NCL); autosomal recessive; neurodegenerative; disorders; Sanger sequencing | ||||
Statistics Article View: 112 PDF Download: 83 |
||||